市场调查报告书
商品编码
1520435
2024-2032 年按材料类型、应用和地区分類的骨科生物材料市场报告Orthopedic Biomaterials Market Report by Material Type, Application, and Region 2024-2032 |
IMARC Group年全球骨科生物材料市场规模达180亿美元。不断增长的老年人口、快速的产品创新、医疗保健行业的显着增长、各种政府倡议的实施以及广泛的研发 (R&D) 活动是推动市场的一些关键因素。
骨科生物材料是骨科手术中用于替代或修復受损骨或关节组织的物质。它们是合成的或天然的,旨在模仿骨骼和关节组织的特性。陶瓷和生物活性玻璃、聚合物、磷酸钙水泥、金属和复合材料是一些常见的材料类型。骨科生物材料广泛用于关节置换手术,例如髋关节、膝关节和肩关节置换、骨折固定、脊椎植入、骨移植和软组织修復。它们具有高强度、延展性、断裂韧性、硬度、耐腐蚀性、成型性和生物相容性。
全球不断增长的老年人口容易遭受骨关节炎、骨质疏鬆症和骨折等各种肌肉骨骼疾病的风险,这是推动市场成长的关键因素之一。与此一致的是,运动伤害、退化性关节疾病和创伤性骨折等骨科疾病和损伤的日益流行,有利于市场的成长。此外,人们对骨科疾病的认识不断提高以及先进治疗解决方案的可用性是另一个促进成长的因素。除此之外,先进生物材料的引入提供了增强的生物相容性、耐用性、机械强度以及与自然组织的融合,提高了骨科植入物的成功率和寿命,为市场成长提供了动力。此外,利用源自天然来源并用于骨科以促进组织再生和癒合的可生物降解材料也有助于市场成长。此外,由于微创(MI)手术具有切口更小、恢復更快、疼痛减轻和住院时间更短等优点,对市场的成长产生了积极影响。其他因素,包括消费者支出能力的提高、广泛的研发(R&D) 活动、对医疗保健基础设施和服务的投资不断增加,以及鼓励医疗保健提供者和患者选择骨科生物材料和手术的各种政府倡议的实施,都在支持市场成长。
The global orthopedic biomaterials market size reached US$ 18.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.9 Billion by 2032, exhibiting a growth rate (CAGR) of 9.22% during 2024-2032. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.
Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.
The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global orthopedic biomaterials market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on material type and application.
Ceramics and Bioactive Glasses
Polymers
Calcium Phosphate Cement
Metal
Composites
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the material type. This includes ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites. According to the report, ceramics and bioactive glasses represented the largest segment.
Orthopedic Implants
Joint Replacement/Reconstruction
Orthobiologics
Viscosupplementation
Bio-Resorbable Tissue Fixation
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the application. This includes orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. According to the report, orthopedic implants represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.